"PharmQuest is a clinical research company."

During the past decade, PharmQuest conducted 48 clinical trials. In the 10-year time frame, 48 clinical trials started and 56 clinical trials were completed, i.e. on average, 116.7% percent of trials that started reached the finish line to date. In the past 5 years, 26 clinical trials started and 35 clinical trials were completed. i.e. 134.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "PharmQuest" #1 sponsor was "Pfizer" with 24 trials, followed by "Eli Lilly and Company" with 17 trials sponsored, "Cephalon" with 4 trials sponsored, "Ferring Pharmaceuticals" with 4 trials sponsored and "BioNTech SE" with 4 trials sponsored. Other sponsors include 25 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "PharmQuest" #1 collaborator was "Pfizer" with 3 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator, "Iqvia Pty Ltd" with 1 trials as a collaborator, "Ironwood Pharmaceuticals, Inc." with 1 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "PharmQuest" are "Migraine" (10 trials), "Osteoarthritis" (9 trials), "Arthritis" (5 trials), "Low Back Pain" (5 trials) and "Type 2 Diabetes Mellitus" (5 trials). Many other conditions were trialed in "PharmQuest" in a lesser frequency.

Most popular intervention types in "PharmQuest" are "Drug" (63 trials), "Biological" (20 trials), "Other" (12 trials), "Behavioral" (2 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (40 trials), "Tirzepatide" (6 trials), "Rimegepant" (5 trials), "Buprenorphine" (3 trials) and "Dihydroergotamine" (3 trials). Other intervention names were less common.

The vast majority of trials in "PharmQuest" are 82 trials for "All" genders.

Currently, there are NaN active trials in "PharmQuest". undefined are not yet recruiting, 1 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 64 completed trials in PharmQuest, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in PharmQuest, 0 "Phase 1" clinical trials were conducted, 26 "Phase 2" clinical trials and 57 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".